DVA DaVita

Q2 2025 10-Q

Filed: Aug 5, 2025Period ending Jun 30, 2025

Health Care

Services-Misc Health & Allied Services, NECSEC EDGAR

DaVita (DVA) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 5, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Risk Factors

• New cybersecurity risk: $13M charges in Q2 2025 from incident remediation, excluded from non-GAAP results reflecting non-recurring nature
• Updated tax risk: Effective income tax rate rose to 31.9% in Q2 2025 from 22.9% in H1 2024, driven by changes in tax expense allocation

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$3.4B

Net Income

$199M

Operating Margin

15.9%

Net Margin

5.9%

Source: XBRL data from DaVita Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other DaVita Quarterly Reports

Q3 2025 10-Q

Get deeper insights on DaVita

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.